Shortage outlook · by company · read 11 November 2026
Which drugs does Gland Pharma Limited have on the FDA shortage list?
Gland Pharma Limited has 20 presentations of 7 drugs on the FDA shortage list, 7 of them reported unavailable. Each is the company's own report to the FDA, with the date of its last update. A report is the company's statement, not a check of any pharmacy's stock.
Gland Pharma Limited has 20 presentations of 7 drugs on the FDA shortage list in 11 November 2026.
The company reported 11 available, 2 with limited availability and 7 unavailable.
Drug by drug, as the company reported it
- Furosemide3 presentations · on the list 6 years and 6 months · last updated 21 October 2026
- Midazolam Hydrochloride2 presentations · on the list 6 years and 6 months · last updated 21 October 2026
- Carboplatin4 presentations · on the list 3 years and 6 months · last updated 21 October 2026
- Metronidazole1 presentation · on the list 4 years and 9 months · last updated 21 October 2026
- Ketorolac Tromethamine5 presentations · on the list 8 years and 7 months · last updated 21 October 2026
- Dexmedetomidine Hydrochloride3 presentations · on the list 6 years and 6 months · last updated 21 October 2026
- Etomidate2 presentations · on the list 4 years · last updated 21 October 2026
FDA current shortage listing file, read 11 November 2026. Availability is the company's own statement to the FDA, not a check of any pharmacy's stock.
Where can you go from here?
Look up any medicine to see how long it has been listed and every company that reports it. The FDA explains what a listing means in the FDA's frequently asked questions about drug shortages, and the list itself is the FDA drug shortages database.